您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报 (医学版) ›› 2019, Vol. 57 ›› Issue (3): 31-37.doi: 10.6040/j.issn.1671-7554.0.2018.763

• • 上一篇    

基于小鼠嗜碱性粒细胞活化致敏性模型的建立

郭岩乳1,孙蓉2,李伟1,刘兆华1   

  1. 1.山东大学药学院新药评价中心, 山东 济南 250012;2.山东省中医药研究院, 山东 济南 250014
  • 发布日期:2022-09-27
  • 通讯作者: 刘兆华. E-mail:17865159131@163.com
  • 基金资助:
    山东省自然科学基金(ZR2012HM056);山东省自主创新及成果转化专项(2014ZZCX02104)

Establishment of sensitization model based on the activation of basophil in mice

GUO Yanru1, SUN Rong2, LI Wei1, LIU Zhaohua1   

  1. 1. Center for New Drug Evaluation School, Pharmaceutical Sciences of Shandong University, Jinan 250012, Shandong, China;
    2. Shandong Academy of Chinese Medicine, Jinan 250014, Shandong, China
  • Published:2022-09-27

摘要: 目的 研究BALB/c致敏小鼠外周血中嗜碱性粒细胞表面分子CD63表达情况,构建小鼠嗜碱性粒细胞激活试验(BAT)模型以评价小分子药物(LMWC)致敏性。 方法 以流式细胞术(CD45 APClow/IgE FITChigh)和瑞氏-姬姆萨染色血涂片检测对照组和卵清蛋白(OVA)致敏小鼠(OVA致敏组)嗜碱性粒细胞的形态和数量;以CD45 APClow/ IgE FITChigh作为鉴定小鼠嗜碱性粒细胞的流式方案,anti-IgE为阳性对照体外与小鼠嗜碱性粒细胞孵育,观察CD63的表达,建立小鼠BAT模型;以青霉素G和BSA的耦联物(PG/BSA)致敏小鼠(PG/BSA致敏组),青霉素G和OVA的耦联物(PG/OVA)体外激发,验证模型的有效性。 结果 与对照组小鼠相比,OVA致敏组小鼠嗜碱性粒细胞的形态和数量差异无统计学意义(P=0.655,P=0.667);anti-IgE 体外可刺激小鼠嗜碱性粒细胞表面CD63的表达;OVA致敏组小鼠外周血体外与OVA孵育后,CD63表达高于对照组[(59.70±37.93)% vs (2.15±1.13)%],差异有统计学意义(P=0.016);PG/BSA致敏组小鼠的外周血体外与PG/OVA孵育后,CD63表达高于对照组[(62.74±41.05)% vs (2.73±1.40)%],差异有统计学意义(P=0.019)。 结论 特定致敏原体外可引起已致敏小鼠的CD63表达上升,表明成功构建了小鼠BAT模型,并以PG验证了此模型的有效性,其可用于评价LMWC的致敏性。

关键词: 嗜碱性粒细胞, 嗜碱性粒细胞激活试验, CD63, 小分子药物, 药物Ⅰ型超敏反应

Abstract: Objective To detect the expression of CD63 of basophil in the peripheral blood of sensitized BALB/c mice, and to establish the basophils activation test(BAT)for assessing the sensitization of low molecule weight compounds(LMWC). Methods The morphology and number of basophils in control BALB/c mice(control group)and ovalbumin(OVA)-sensitized BALB/c mice(OVA-sensitized group)were determined by flow cytometry(CD45 APClow/IgE FITChigh)and peripheral blood smears stained by Wright-Giemsa. CD45 APClow/IgE FITChigh was used as the flow scheme to identify mice basophils, and anti-IgE was used as a positive control to incubate with basophils in vitro to observe the expression of CD63 and establish the BAT of mice. In addition, the BALB/c mice was sensitized with penicillin G conjugated BSA(PG/BSA group), and the blood was stimulated by penicillin G-conjugated OVA(PG/OVA)in vitro to observe the expression of CD63, thereby detect the effectiveness of BAT. Results Flow cytometry and blood smears showed that the morphology and numbers of basophils in control group and OVA-sensitized 山 东 大 学 学 报 (医 学 版)57卷3期 -郭岩乳,等.基于小鼠嗜碱性粒细胞活化致敏性模型的建立 \=-group had no significant difference(P=0.655,P=0.667). Anti-IgE could stimulate the expression of CD63 on basophils. After the incubation with OVA in vitro, the CD63 expression in peripheral blood of the OVA-sensitized group was higher than the control group[(59.70±37.93)% vs (2.15±1.13)%, P=0.016]. After the incubation with PG/BSA in vitro, the CD63 expression in peripheral blood of the PG/BSA-sensitized group was higher than the control group[(62.74±41.05)% vs (2.73±1.40)%,P=0.019]. Conclusion Specific allergen in vitro can lead to increased CD63 expression in the sensitized mice, indicating the successful construction of BAT in mice, which is effective verified by PG and can be used to evaluate the sensitization of LMWC.

Key words: Basophils, Basophil activation test, CD63, Low molecule weight compounds, Drug type Ⅰ hypersensitivity

中图分类号: 

  • R619
[1] 蔡强, 王秀问, 方英立, 等. 奥沙利铂过敏反应临床资料分析[J]. 山东大学学报(医学版), 2011, 49(12):149-152. CAI Qiang, WANG Xiuwen, FANG Yingli, et al. A clinical analysis of hypersensitivity reactions oxaliplatin[J].Iournal of Shandong University(Health Sciences). 2011, 49(12):149-152.
[2] Muraro A, Lemanske RF Jr, Castells M, et al. Precision medicine in allergic disease-food allergy, drug allergy, and anaphylaxis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma and Immunology[J]. Allergy, 2017, 72(7): 1006-1021.
[3] Schneider CH, de Weck AL. A new chemical aspect of penicillin allergy: the direct reaction of penicillin with ε-amino-groups[J]. Nature, 1965, 208(5005): 57-59.
[4] Simons FE, Frew AJ, Ansotegui IJ, et al. Risk assessment in anaphylaxis: current and future approaches[J]. J Allergy Clin Immunol, 2007, 120(1 Suppl): S2-24.
[5] FDA. Guidance for Industry Immunology Evaluation of Invesigational New Drugs[S]. 2002: 1-38.
[6] 药物刺激性、过敏性和溶血性研究技术指导原则[S].2014:1-22.
[7] Pieters R. The popliteal lymph node assay: a tool for predicting drug allergies[J]. Toxicology, 2001, 158(1-2):65-69.
[8] Ravel G, Descotes J. Popliteal lymph node assay: facts and perspectives[J]. J Appl Toxicol, 2005, 25(6): 451-458.
[9] Ebo DG, Sainte-Laudy J, Bridts CH, et al. Flow-assisted allergy diagnosis: current applications and future perspectives[J]. Allergy, 2006, 61(9): 1028-1039.
[10] Hoffmann HJ, Santos AF, Mayorga C, et al. The clinical utility of basophil activation testing in diagnosis and monitoring of allergic disease[J]. Allergy, 2015, 70(11): 1393-1405.
[11] Larsen LF, Juel-Berg N, Hansen KS, et al. A comparative study on basophil activation test, histamine release assay, and passive sensitization histamine release assay in the diagnosis of peanut allergy[J]. Allergy, 2018, 73(1): 137-144.
[12] Song WJ, Chang YS. Recent applications of basophil activation tests in the diagnosis of drug hypersensitivity[J]. Asia Pac Allergy, 2013, 3(4): 266-280.
[13] Sudheer PS, Hall JE, Read GF, et al. Flow cytometric investigation of peri-anaesthetic anaphylaxis using CD63 and CD203c[J]. Anaesthesia, 2005, 60(3): 251-256.
[14] Hagau N, Gherman-Ionica N, Sfichi M, et al. Threshold for basophil activation test positivity in neuromuscular blocking agents hypersensitivity reactions[J]. Allergy Asthma Clin Immunol, 2013, 9(1): 42. doi:10.1186/1710-1492-9-42.
[15] Torrero MN, Larson D, Hübner MP, et al. CD200R surface expression as a marker of murine basophil activation[J]. Clin Exp Allergy, 2009, 39(3): 361-369.
[16] Schwartz C, Voehringer D. Identification of murine basophils by flow cytometry and histology[J]. Methods Mol Biol, 2014, 1192: 229-237. doi:10.1007/978-1-4939-1173-8_17.
[17] 陈典. 利用小鼠嗜碱性粒细胞活化标志研究中药注射剂的致敏性[D]. 广州:广州中医药大学, 2012.
[18] Nagao K, Yokoro K, Aaronson SA. Continuous lines of basophil/mast cells derived from normal mouse bone marrow[J]. Science, 1981, 212(4492): 333-335.
[19] Shelley WB. The absolute basophil count[J]. JAMA, 1965, 192(5): 368-370.
[20] 郭利利, 陈军浩, 顾光煜, 等. 流式细胞术计数外周血嗜碱性粒细胞[J]. 现代检验医学杂志, 2008, 23(2): 91-93. GUO Lili, CHEN Junhao, GU Gangyu, et al. A novel method for enumeration of basophiles in peripheral blood by flow cytometry[J]. Journal of Modern Laboratory Medicine, 2008, 23(2):91-93.
[21] Santos AF, Lack G. Basophil activation test: food challenge in a test tube or specialist research tool?[J]. Clin Transl Allergy, 2016, 6: 10. doi:10.1186/s13601-016-0098-7.
[22] Chomiciene A, Jurgauskiene L, Kowalski ML, et al. Serum induced CD63 and CD203c activation tests in chronic urticaria[J]. Cent Eur J Med, 2014, 9(2): 339-347.
[23] Giavina-Bianchi P, Galvão VR, Picard M, et al. Basophil activation test is a relevant biomarker of the outcome of rapid desensitization in platinum compounds-allergy[J]. J Allergy Clin Immunol Pract, 2017, 5(3): 728-736.
[24] 景丽霞, 郭相杰, 靳茜茜, 等. 过敏性休克大鼠血嗜碱性粒细胞CD63的表达[J]. 法医学杂志, 2012, 28(3): 172-174. JING Lixia, GUO Xiangjie, JIN Qianqian,et al. Basophil CD63 expression in the blood of the anaphylactic shock rat[J] Journal of Forensic Medicine, 2012, 28(3): 172-174.
[25] Hennersdorf F, Florian S, Jakob A, et al. Identification of CD13, CD107a, and CD164 as novel basophil-activation markers and dissection of two response patterns in time kinetics of IgE-dependent upregulation[J]. Cell Res, 2005, 15(5): 325-335.
[26] MacGlashan D Jr. Expression of CD203c and CD63 in human basophils: relationship to differential regulation of piecemeal and anaphylactic degranulation processes[J]. Clin Exp Allergy, 2010, 40(9): 1365-1377.
[27] Aerts NE, Dombrecht EJ, Bridts CH, et al. Simultaneous flow cytometric detection of basophil activation marker CD63 and intracellular phosphorylated p38 mitogen-activated protein kinase in birch pollen allergy[J]. Cytometry B Clin Cytom, 2009, 76(1): 8-17.
[28] Cliquet P, Cox E, Van Dorpe C, et al. Generation of class-selective monoclonal antibodies against the penicillin group[J]. J Agric Food Chem, 2001, 49(7): 3349-3355.
[29] Kimber I, Betts CJ, Dearman RJ. Assessment of the allergenic potential of proteins[J]. Toxicol Lett, 2003, 140-141: 297-302.
[30] Fernández TD, Torres MJ, Blanca-López N, et al. Negativization rates of IgE radioimmunoassay and basophil activation test in immediate reactions to penicillins[J]. Allergy, 2009, 64(2): 242-248.
[31] Cooper AD, Balakrishnan K, McConnell HM. Mobile haptens in liposomes stimulate serotonin release by rat basophil leukemia cells in the presence of specific immunoglobulin E[J]. J Biol Chem, 1981, 256(18): 9379-9381.
[32] Kane P, Holowka D, Baird B. Characterization of model antigens composed of biotinylated haptens bound to avidin[J]. Immunol Invest, 1990, 19(1): 1-25.
[33] 潘庆军, 刘渊, 富宁. 嗜碱性粒细胞在过敏和免疫反应中的研究进展[J]. 中国免疫学杂志, 2009, 25(7): 671-673. PAN Qingjun, LIU Yuan, FU Ning. Research progress of basophils in allergy and immune response[J]. Chinese Journal of Immunology, 2009, 25(7): 671-673.
[1] 周苗,卞伟玮,柳晓涓,康凤玲,薛付忠,刘静. 嗜碱性粒细胞百分比与慢性肾脏病关系的回顾性队列研究[J]. 山东大学学报 (医学版), 2018, 56(3): 85-90.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!